Literature DB >> 33495079

The proteostatic network chaperome is downregulated in F508del homozygote cystic fibrosis.

Marc A Sala1, Michael Alexander1, Basil Khuder1, Yuliya Politanska1, Hiam Abdala-Valencia1, G R Scott Budinger1, Jing Liu2, Manu Jain3, Paul A Reyfman1.   

Abstract

BACKGROUND: CF patients demonstrate clinical heterogeneity and much remains unknown about how to risk stratify individuals for disease progression.  The most common cystic fibrosis mutation, F508del, is a protein folding mutation that has been shown in vitro to negatively affect proteostasis and CFTR transcription. Since CFTR is expressed in the nasal epithelium, we hypothesized that by using unbiased transcriptomics we could gain clinically relevant insights about differential gene expression and heterogeneity in CF patients as well as assess proteostatic dysfunction in the nasal epithelium.
METHODS: Using nasal curettage and RNA-seq we assessed differential gene expression in F508del homozygotes compared to healthy volunteers. Gene set enrichment analysis was performed using a list of known chaperones. Pilot and validation cohorts were studied.
RESULTS: PCA analysis and gene expression heatmaps exhibited greater heterogeneity among CF than healthy volunteers. Differentially expressed genes were enriched for the downregulation of ciliary/microtubular genes and the upregulation of inflammatory/immune response genes in F508del homozygotes compared to healthy volunteers. Gene set analysis identified negative enrichment for chaperone genes and decreased CFTR transcription in the F508del homozygotes. We also found preliminary evidence for the recently identified ionocyte in the nasal specimens.
CONCLUSION: CF patients homozygous for F508del demonstrate heterogeneous gene expression profiles, proteostatic dysregulation, and reduced CFTR transcription. Larger studies are needed to determine whether nasal epithelial gene transcription profiles can be leveraged for insights into disease heterogeneity.
Copyright © 2020 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chaperones; Ionocyte; Nasal epithelium; Proteostasis; Transcriptomics

Mesh:

Substances:

Year:  2021        PMID: 33495079      PMCID: PMC8900221          DOI: 10.1016/j.jcf.2020.12.018

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.527


  23 in total

1.  Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function.

Authors:  J Michael Collaco; Scott M Blackman; John McGready; Kathleen M Naughton; Garry R Cutting
Journal:  J Pediatr       Date:  2010-06-30       Impact factor: 4.406

2.  Differential global gene expression in cystic fibrosis nasal and bronchial epithelium.

Authors:  Varrie Ogilvie; Margaret Passmore; Laura Hyndman; Lisa Jones; Barbara Stevenson; Abigail Wilson; Heather Davidson; Robert R Kitchen; Robert D Gray; Pallav Shah; Eric W Alton; Jane C Davies; David J Porteous; A Christopher Boyd
Journal:  Genomics       Date:  2011-07-02       Impact factor: 5.736

3.  Similarities and differences between smoking-related gene expression in nasal and bronchial epithelium.

Authors:  Xiaoling Zhang; Paola Sebastiani; Gang Liu; Frank Schembri; Xiaohui Zhang; Yves Martine Dumas; Erika M Langer; Yuriy Alekseyev; George T O'Connor; Daniel R Brooks; Marc E Lenburg; Avrum Spira
Journal:  Physiol Genomics       Date:  2009-12-01       Impact factor: 3.107

4.  Genetic modifiers of lung disease in cystic fibrosis.

Authors:  Mitchell L Drumm; Michael W Konstan; Mark D Schluchter; Allison Handler; Rhonda Pace; Fei Zou; Maimoona Zariwala; David Fargo; Airong Xu; John M Dunn; Rebecca J Darrah; Ruslan Dorfman; Andrew J Sandford; Mary Corey; Julian Zielenski; Peter Durie; Katrina Goddard; James R Yankaskas; Fred A Wright; Michael R Knowles
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

5.  The relationship between sweat chloride levels and mortality in cystic fibrosis varies by individual genotype.

Authors:  Julia C Espel; Hannah L Palac; Ankit Bharat; Joanne Cullina; Michelle Prickett; Marc Sala; Susanna A McColley; Manu Jain
Journal:  J Cyst Fibros       Date:  2017-12-06       Impact factor: 5.482

6.  limma powers differential expression analyses for RNA-sequencing and microarray studies.

Authors:  Matthew E Ritchie; Belinda Phipson; Di Wu; Yifang Hu; Charity W Law; Wei Shi; Gordon K Smyth
Journal:  Nucleic Acids Res       Date:  2015-01-20       Impact factor: 16.971

7.  Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.

Authors:  Deepika Polineni; Hong Dang; Paul J Gallins; Lisa C Jones; Rhonda G Pace; Jaclyn R Stonebraker; Leah A Commander; Jeanne E Krenicky; Yi-Hui Zhou; Harriet Corvol; Garry R Cutting; Mitchell L Drumm; Lisa J Strug; Michael P Boyle; Peter R Durie; James F Chmiel; Fei Zou; Fred A Wright; Wanda K O'Neal; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

8.  The mechanism of cystic fibrosis transmembrane conductance regulator transcriptional repression during the unfolded protein response.

Authors:  Rafal Bartoszewski; András Rab; George Twitty; Lauren Stevenson; James Fortenberry; Arkadiusz Piotrowski; Jan P Dumanski; Zsuzsa Bebok
Journal:  J Biol Chem       Date:  2008-03-04       Impact factor: 5.157

9.  A revised airway epithelial hierarchy includes CFTR-expressing ionocytes.

Authors:  Daniel T Montoro; Adam L Haber; Moshe Biton; Vladimir Vinarsky; Brian Lin; Susan E Birket; Feng Yuan; Sijia Chen; Hui Min Leung; Jorge Villoria; Noga Rogel; Grace Burgin; Alexander M Tsankov; Avinash Waghray; Michal Slyper; Julia Waldman; Lan Nguyen; Danielle Dionne; Orit Rozenblatt-Rosen; Purushothama Rao Tata; Hongmei Mou; Manjunatha Shivaraju; Hermann Bihler; Martin Mense; Guillermo J Tearney; Steven M Rowe; John F Engelhardt; Aviv Regev; Jayaraj Rajagopal
Journal:  Nature       Date:  2018-08-01       Impact factor: 49.962

10.  Changes in transcriptome of native nasal epithelium expressing F508del-CFTR and intersecting data from comparable studies.

Authors:  Luka A Clarke; Lisete Sousa; Celeste Barreto; Margarida D Amaral
Journal:  Respir Res       Date:  2013-03-28
View more
  1 in total

1.  Expression of ACE2-a Key SARS-CoV-2 Entry Factor-Is Not Increased in the Nasal Mucosa of People with Cystic Fibrosis.

Authors:  Marc A Sala; Nikolay S Markov; Yuliya Politanska; Hiam Abdala-Valencia; Alexander V Misharin; Manu Jain
Journal:  Am J Respir Cell Mol Biol       Date:  2022-07       Impact factor: 7.748

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.